Related Experiment Video
Updated: Jun 8, 2026

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
Published on: January 9, 2026
Relationship between severe obesity and gut inflammation in children: what's next?
Maria Immacolata Spagnuolo1, Maria Pia Cicalese, Maria Angela Caiazzo
1Department of Paediatrics University Federico II, Naples, Italy. mispagnu@unina.it
Insights
Obese children frequently have glucose abnormalities and inflammation. Gut and systemic inflammation correlate with these glucose issues, highlighting a link between obesity, inflammation, and metabolic dysfunction in pediatric populations.
Area of Science:
- Pediatric Endocrinology
- Gastroenterology
- Metabolic Syndrome
Background:
- Obesity is increasingly linked to gut inflammation in preliminary studies.
- Understanding this association is crucial for pediatric health outcomes.
Purpose of the Study:
- To determine the prevalence of glucose abnormalities in severely obese children.
- To investigate the correlation between systemic and intestinal inflammation and glucose metabolism in this cohort.
Main Methods:
- Thirty-four severely obese children (BMI >95th percentile) underwent screening.
- Tests included oral glucose tolerance test (OGTT), C-reactive protein (CRP), fecal calprotectin, and rectal nitric oxide (NO).
Main Results:
- 71% of children exhibited glucose abnormalities, including type 2 diabetes (29%), impaired fasting glucose (58%), and impaired glucose tolerance (37.5%).
- Elevated CRP (73.5%), fecal calprotectin (47%), and nitric oxide (88%) were common.
- Significant correlations were found between BMI z-score and CRP, and between inflammation markers and abnormal glucose metabolism.
Conclusions:
- Severely obese children show a high prevalence of glucose abnormalities.
- Systemic and intestinal inflammation markers are correlated with glucose abnormalities in these children, suggesting a shared inflammatory pathway.
Background:
Preliminary evidence suggests an association between obesity and gut inflammation.
Aims:
To evaluate the frequency of glucose abnormalities and their correlation with systemic and intestinal inflammation in severely obese children.
Patients And Methods:
Thirty-four children (25 males; median age 10.8 ± 3.4 yrs) with severe obesity (BMI >95%) were screened for diabetes with oral glucose tolerance test (OGTT), systemic inflammation with C-reactive protein (CRP) and gut inflammation with rectal nitric oxide (NO) and faecal calprotectin.
Results:
BMI ranged from 23 to 44 kg/m2, and BMI z-score between 2.08 e 4.93 (median 2.69 ± 0.53). Glucose abnormalities were documented in 71% of patients: type 2 diabetes in 29%, impaired fasting glucose (IFG) in 58%, and impaired glucose tolerance (IGT) in 37.5%. Thirty-one patients (91%) were hyperinsulinemic. CRP was increased in 73.5% with a correlation between BMI z-score and CRP (p 0.03). Faecal calprotectin was increased in 47% patients (mean 77 ± 68), and in 50% of children with abnormal glucose metabolism (mean 76 ± 68 μg/g), with a correlation with increasing BMI z-score. NO was pathological in 88%, and in 87.5% of glucose impairment (mean 6.8 ± 5 μM).
Conclusions:
In this study, the prevalence of glucose abnormalities in obese children is higher than in other series; furthermore, a correlation is present between markers of systemic and intestinal inflammation and glucose abnormalities.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
